According to the results of CCK8 assays, transwell assays and cell cycle analysis, we found that CDCA3 had the capacity to enhance the proliferation, invasion and migration of RCC cells (Supplementary Fig. 4b–f). This evidence concerns the gene CDCA3 and renal cell carcinoma.